Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes.
Transfusion 44(8):1143-8 (2004) PMID 15265117
Platelet (PLT) transfusions are administered in cardiac surgery to prevent or treat bleeding, despite appreciation of the risks of blood component transfusion. The current analysis investigates the hypothesis that PLT transfusion is associated with adverse outcomes associated with coronary artery bypass graft surgery (CABG).
DOI: 10.1111/j.1537-2995.2004.03322.xVersion: za2963e q8za6 q8zbc q8zcb q8zda q8ze1 q8zf1 q8zga